Literature DB >> 21755534

Bone geometry profiles in women with and without SLE.

Jimmy D Alele1, Diane L Kamen, Kelly J Hunt, Rosalind Ramsey-Goldman.   

Abstract

Recent studies have reported an increased risk of fracture among patients with systemic lupus erythematosus (SLE) in comparison with the general population. The aim of this study was to examine associations between SLE status and bone geometry in white and African-American women. We compared hip BMD and bone geometry parameters among SLE women and control individuals using hip structure analysis (HSA). One-hundred and fifty-three dual-energy X-ray absorptiometry (DXA) scans from the Study of Lupus Vascular and Bone Long Term Endpoints (68.7% white and 31.3% African American) and 4920 scans from the Third National Health and Nutrition Examination Survey (59.3% white and 40.7% African American) were analyzed. Linear regression was used to examine BMD and bone geometry differences by SLE status and by race/ethnicity after adjusting for age and BMI. Significant differences were detected between SLE and control women. Among white women, age-adjusted BMD (g/cm(2)), section modulus (cm(3)), and cross-sectional areas (cm(2)) were lower among SLE women than among control women at the narrow neck (0.88 versus 0.83 g/cm(2), 1.31 versus 1.11 cm(2), and 2.56 versus 2.40 cm(2), p < 0.001, p < 0.01, and p < 0.0001, respectively), whereas buckling ratio was increased (10.0 versus 10.6, p < 0.01). Likewise, BMD, section modulus, and cross-sectional areas were decreased among African-American SLE women at all subregions, whereas buckling ratios were increased. There were significant bone geometry differences between SLE and control women at all hip subregions. Bone geometry profiles among SLE women were suggestive of increased fragility.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Year:  2011        PMID: 21755534      PMCID: PMC4847947          DOI: 10.1002/jbmr.466

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  44 in total

Review 1.  Osteoporosis in Cushing's syndrome.

Authors:  Gregory Kaltsas; Luca Manetti; Ashley B Grossman
Journal:  Front Horm Res       Date:  2002       Impact factor: 2.606

2.  Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women.

Authors:  D A Nelson; D A Barondess; S L Hendrix; T J Beck
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 3.  Osteoporotic fractures in older adults.

Authors:  Cathleen S Colón-Emeric; Kenneth G Saag
Journal:  Best Pract Res Clin Rheumatol       Date:  2006-08       Impact factor: 4.098

4.  Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial.

Authors:  K Uusi-Rasi; T J Beck; L M Semanick; M M Daphtary; G G Crans; D Desaiah; K D Harper
Journal:  Osteoporos Int       Date:  2006-01-04       Impact factor: 4.507

5.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

Review 6.  Use of oral corticosteroids and risk of fractures.

Authors:  T P Van Staa; H G Leufkens; L Abenhaim; B Zhang; C Cooper
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

7.  Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data.

Authors:  R Ramsey-Goldman; J E Dunn; C F Huang; D Dunlop; J E Rairie; S Fitzgerald; S Manzi
Journal:  Arthritis Rheum       Date:  1999-05

8.  Loss of trabecular bone mineral density in systemic lupus erythematosus.

Authors:  A A Kalla; A B Fataar; S J Jessop; L Bewerunge
Journal:  Arthritis Rheum       Date:  1993-12

9.  Self-reported fractures and associated factors in women with systemic lupus erythematosus.

Authors:  Chin Lee; Orit Almagor; Dorothy D Dunlop; Susan Manzi; Stewart Spies; Rosalind Ramsey-Goldman
Journal:  J Rheumatol       Date:  2007-09-01       Impact factor: 4.666

10.  BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.

Authors:  Katie L Stone; Dana G Seeley; Li-Yung Lui; Jane A Cauley; Kristine Ensrud; Warren S Browner; Michael C Nevitt; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2003-11       Impact factor: 6.741

View more
  5 in total

Review 1.  Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  X Wang; S Yan; C Liu; Y Xu; L Wan; Y Wang; W Gao; S Meng; Y Liu; R Liu; D Xu
Journal:  Osteoporos Int       Date:  2016-01-11       Impact factor: 4.507

2.  Dissecting the relationship between high-sensitivity serum C-reactive protein and increased fracture risk: the Rotterdam Study.

Authors:  L Oei; N Campos-Obando; A Dehghan; E H G Oei; L Stolk; J B J van Meurs; A Hofman; A G Uitterlinden; O H Franco; M C Zillikens; F Rivadeneira
Journal:  Osteoporos Int       Date:  2013-12-13       Impact factor: 4.507

Review 3.  Bone quality: the determinants of bone strength and fragility.

Authors:  Hélder Fonseca; Daniel Moreira-Gonçalves; Hans-Joachim Appell Coriolano; José Alberto Duarte
Journal:  Sports Med       Date:  2014-01       Impact factor: 11.136

4.  Prevalence and predictors of low bone density and fragility fractures in women with systemic lupus erythematosus in a Mediterranean region.

Authors:  Tarek Carlos Salman-Monte; Vicenç Torrente-Segarra; Juan Muñoz-Ortego; Sergi Mojal; Jordi Carbonell-Abelló
Journal:  Rheumatol Int       Date:  2014-07-17       Impact factor: 2.631

Review 5.  Bone mineral density and vertebral fractures in patients with systemic lupus erythematosus: A systematic review and meta-regression.

Authors:  Claudia Mendoza-Pinto; Adriana Rojas-Villarraga; Nicolás Molano-González; Erick A Jiménez-Herrera; María de la Luz León-Vázquez; Álvaro Montiel-Jarquín; Mario García-Carrasco; Ricard Cervera
Journal:  PLoS One       Date:  2018-06-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.